Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Ovarian Cancer

Conditions:   Ovarian Cancer;   Low Grade Serous Carcinoma;   Primary Peritoneal Carcinoma;   Fallopian Tube Cancer Intervention:   Drug: Pembrolizumab Sponsors:   North Eastern German Society of Gynaecological Oncology;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials